Abstract
Get full access to this article
View all access options for this article.
References
1.Eli Lilly and Company . Atomoxetine (Strattera) prescribing information . http://pi.lilly.com/us/strattera-pi.pdf . 2013 February 15 .
2.
Koliscak
LP
,
Makela
EH
. Selective serotonin reuptake inhibitor-induced akathisia . J Am Pharm Assoc , 49 :e28 –e38 . 2009 .
3.
Lane
RM
. SSRI-induced extrapyramidal side-effects and akathisia: Implications for treatment . J Psychopharmacol , 12 :192 –214 . 1998 .
4.
Lipinski
JF
,
Mallya
G
,
Zimmerman
P
,
Pope
HG
. Fluoxetine-induced akathisia: Clinical and theoretical implications . J Clin Psychiatry , 50 :339 –342 . 1989 .
5.
Sauer
JM
,
Ring
BJ
,
Witcher J
W
. Clinical pharmacokinetics of atomoxetine . Clin Pharmacokinet , 44 :571 –590 . 2005 .
6.
Tassin
JP
,
Stinus
L
,
Simon
H
,
Blanc
G
,
Thierry
AM
,
Le Moal
M
,
Cardo
B
,
Glowinski
J
. Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the frontocortical dopaminergic innervation in the rat . Brain Res , 141 :267 –281 . 1978 .